DB00267ApprovedSmall molecule
Cefmenoxime is a novel broad-spectrum and third-generation cephalosporin antibiotic that is typically used in the treatment of female gynecologic and obstetric infections. It is reported to exhibit high activity against...
- Mechanism
- Curator reviewed
The bactericidal activity of cefmenoxime results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cefmenoxime is stable in the presence of a variety of b-lactamases, including penicillinases and some cephalosporinases.
- Primary indication
- Used to treat female gynecologic and obstetric infections caused by susceptible aerobic (including the gonococcus) and anaerobic bacteria.Curator reviewed
- Formula / weight
- C16H17N9O5S3 · 511.558 g/mol (avg)
- Code names
- SCE-1365
Resolves to
Clinical / RWD
Structure
InChIKey
HJJDBAOLQAWBMH-YCRCPZNHSA-NSMILES[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=OTargets
What you can answer from here — as of September 12, 2026
3Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with Cefmenoxime, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account